In Regard to Nath et al. (2022) (doi: 10.1007/s12070-021-02941-x)

In Regard to Vaidya et al.

Leukemia Group B 9343, which showed that locoregional recurrence continues to occur beyond 5 years (7). Furthermore, when compared with the initial results (5), the updated results of TARGIT-A (4) demonstrate a much higher increase in the rate of local recurrences for PBI (23 vs 6) compared with external beam radiotherapy group (11 vs 5). Further, we disagree with the authors (1) that this shor...

Reply to X. Qi et al.

TO THE EDITOR: Nowadays, the position of sorafenib in the treatment of advanced hepatocellular carcinoma (HCC) is frequently challenged by other molecular targeted agents. However, regardless of whether they are considered as first-line or second-line treatment options, all completed phase III randomized controlled trials (RCTs) report negative results. Similarly, two phase III RCTs (Comparison...

microleakage evaluation in regard to cavo-surface designs & treatments

چکیده ندارد.

In Response to Fakruddin et al. and Apostolou et al

In Response to Fakruddin et al. dicted to result in substitutions of amino acids at the and Apostolou et al. corresponding positions in the protein sequence. In each of these cases, individual tumor DNA samples possessed the same sequence as that of the corresponding cell line. We agree with many of the above findings, including To determine if the divergent sequences represented the frequency ...

In Response to Murphy et al., Löwer et al., and Lan et al